SHENZHEN, China, Jan. 2 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced the appointment of Peter Hsu as vice president of sales, marketing and services for North America.
“We are very pleased to welcome Mr. Hsu to our team,” said Mr. Xu Hang, Mindray’s chairman and co-chief executive officer. “Mr. Hsu brings valuable U.S. market experience and has executed strategies accelerating growth in high potential markets around the world. I am confident his extensive background in the medical device industry will allow him to make an immediate impact on our growth in North America.”
“We view the U.S. market as strategically important in the long term,” added Mr. Li Xiting, Mindray’s president and co-chief executive officer. “With our expanding R&D and sales and marketing operations in Seattle, and with 11 products having received FDA 510(k) clearance, and up to 5 more expected to be approved in 2008, we are fully committed to continuing our investment in the U.S. We are excited to add Mr. Hsu’s tremendous experience to our senior management team as we continue to grow our international business.”
Mr. Hsu brings more than 25 years of experience in medical device sales and marketing as well as strategic management. Mr. Hsu will be responsible for sales, marketing and services of our products in North America markets. Prior to joining Mindray, Mr. Hsu was managing director of SonoSite in North Asia and prior to that he was senior director of global strategic market development of cardiac and monitoring systems for Philips Medical Systems in Andover, Massachusetts. Previously, he also served as senior director of Asia Pacific for Philips Medical Systems’ ultrasound business line and as vice president and general manager of Asia Pacific for Hewlett Packard’s Medical Products Group. Mr. Hsu holds bachelor’s degrees in Electronics Engineering and Electrical Engineering from National Taiwan Institute of Technology.
About Mindray
Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in China with a significant and growing presence worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems. Mindray is headquartered in Shenzhen, China, and has 29 local sales and service offices in China, as well as sales and service offices in Amsterdam, Boston, Istanbul, London, Mexico City, Mumbai, Sao Paulo, Seattle, Toronto and Vancouver. For more information, please visit http://www.mindray.com .
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the ‘‘safe harbor’’ provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Statements that are not historical facts, including statements about Mindray’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Information regarding these risks and uncertainties is included in our public filings with the Securities and Exchange Commission. All information provided in this press release is as of January 2, 2008, and Mindray undertakes no duty to update such information, except as required under applicable law.
For investor and media inquiries, please contact:
In China:
Investor Relations
Mindray Medical International Limited
Tel: +86-755-2658-2518
Email: IR@Mindray.com
Justin Knapp
Ogilvy Public Relations Worldwide, Beijing
Tel: +86-10-8520-6556
Email: Justin.Knapp@Ogilvy.com
In the United States:
Jeremy Bridgman
Ogilvy Public Relations Worldwide, New York
Tel: +1-212-880-5363
